---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-019059"
form_type: "8-K"
ticker: "BLGO"
cik: "0000880242"
company_name: "BIOLARGO, INC."
filed_at: "2022-08-05T23:59:59+00:00"
generated_at: "2026-06-24T03:33:09.301210+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# BioLargo Q2 2022 revenue ~$1.3M, up 185% YoY; preliminary figures

## Summary
- Q2 revenue ~$1.3M, up 37% sequentially and 185% vs Q2 2021.
- Growth driven by POOPH retail launch, PFAS treatment tech, waste-to-energy project.
- National nuclear fuel innovator prototype project expected to expand after successful Phase 1.
- Full Q2 results due in Form 10-Q by Aug 15, 2022; figures preliminary and unaudited.
- Company plans investor webcast shortly after 10-Q filing.

## SEC filing metadata
- accession: 0001437749-22-019059
- form_type: 8-K
- ticker: BLGO
- cik: 0000880242
- company_name: BIOLARGO, INC.
- filed_at: 2022-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/880242/000143774922019059/0001437749-22-019059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/880242/000143774922019059/blgo20220804_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-019059
- JSON: https://secwatch.observer/filing/0001437749-22-019059.json
- Plain text: https://secwatch.observer/filing/0001437749-22-019059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.